Abstract
Polymer-lipid nanoparticles enhance liver-targeted delivery of therapeutic base editor plasmid for the treatment of hereditary tyrosinemia type 1 (HT-1)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have